Elementis plc - Unsponsored ADR (ELMTY)
OTC PINK OTC PINK Primary 
Elementis plc (ELMTY) Q2 2026 Earnings Call Transcript
Elementis plc (ELMTY) Q2 2026 Earnings Call Transcript
Elementis H1 Earnings Call Highlights
Elementis LON: ELM reported higher first-half revenue, profit and margins as the specialty chemicals company advanced its Elevate Elementis strategy, while management said it remains confident of meeting full-year 2026 expectations despite mixed market conditions.
Elementis jumps after selling pharma manufacturing arm to AB Foods
Elementis plc (LSE:ELM) shares rose 6.2% to 161.2p after the speciality chemicals group completed the sale of its pharmaceutical manufacturing business to Associated British Foods PLC (LSE:ABF) and said it would return the proceeds to shareholders through a share buyback. The company confirmed completion of the disposal for an enterprise value of €34.3 million ($39.8 million) and, after transaction costs, expects to receive net cash proceeds of about €30 million (roughly $35 million), all of which will be returned to shareholders via a share repurchase programme that is expected to begin as soon as practicable.
Elementis plc (ELMTY) Q4 2025 Earnings Call Transcript
Elementis plc (ELMTY) Q4 2025 Earnings Call Transcript
Elementis shares elevated after selling off talc arm
Elementis plc (LSE:ELM) shares jumped 10% as it completed the sale of its talc business and said it will give most of the proceeds to investors in the form of a share buyback. The soapstone business has been sold to Italy's IMI Fabi for net cash proceeds after transaction costs of roughly $55 million, or almost £41 million.
Elementis: Decreasing Net Debt Makes Stock Attractive
Elementis delivered robust 2024 results, with improved gross profit and cash flow despite a reported net loss due to a talc business impairment. Q1 2025 update shows margin improvement and cost savings progress, reinforcing management's 2026 targets for higher margins and return on capital. Strategic review of the talc business continues; a sale could boost margins and reduce debt, but risks selling a valuable asset below its purchase price.
